CHRISTIN BLAZEVICH: Open Payments
NPI 1831836956 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 7 payments from 4 companies in 2025. Trend: 2023 $268 · 2024 $157 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 1 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Abbott Laboratories | 1 | $25 |
Products named: LEQVIO, CAMZYOS, LIVTENCITY.
Industry payments across TX — which companies pay providers there.
